ResMed Inc. (RMD) Stock Price & Analysis
Market: NYSE • Sector: Healthcare • Industry: Medical - Instruments & Supplies
ResMed Inc. (RMD) Profile & Business Summary
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Key Information
| Ticker | RMD |
|---|---|
| Exchange | NYSE |
| Official Site | https://www.resmed.com |
Market Trend Overview for RMD
One model, two time views: what the market looks like right now, and where the larger trend is heading over time.
SRE (WhaleQuant Structural Regime Engine) SRE evaluates how price structure evolves across daily and weekly timeframes to define the prevailing market regime. Beyond identifying trends, consolidations, and exhaustion phases, it distinguishes between raw structural strength and deployable participation quality. The model dynamically adjusts for structural context and extension risk, assessing whether conditions are supportive, stretched, fragile, or structurally impaired. Its purpose is not to forecast precise price levels, but to determine whether risk deployment is aligned with underlying market structure.
Longer-Term Market Trend (Mid to Long Term)
Shows the bigger market trend, how strong it is, and where risks may start to build over the next few weeks or months. — Updated as of 2026-07-14 (ET)
As of 2026-07-14, RMD is showing signs of slowing down. Over the longer term, the trend remains bearish.
RMD last closed at 193.01. The price is about 2.4 ATR below its recent average price (207.56), and the market is currently in a trend that may be losing strength. Price at 193.01 is near light support around 192.81. Momentum may slow, while minor resistance sits near 199.99. View Support & Resistance from Options
Short-term strength is developing against a weaker long-term trend, which increases the risk of downside reversals.
Trend score: 45 out of 100. Overall alignment is unclear. The market is currently in a late-stage trend that may be losing strength. The longer-term trend is still negative, but short-term signals are not yet confirming it.
Price is stretched well below its recent average (about 2.4 ATR). Downside extension is elevated, and chasing weakness here carries a higher rebound risk.
A key downside risk boundary is near 182.61. If price falls below this area, the current structure would likely weaken further.
On 2026-07-14, trend conditions deteriorated, suggesting that moves in the prior direction became less dependable.
[2026-07-01] Price moved quickly and looked strong, but participation was limited.
Recent price action continues to trend lower in a relatively orderly manner, with no clear signs of structural stabilization yet emerging.
There was no clear sign of meaningful positions being carried into the overnight session.
The model does not deploy the setup because the current position looks stretched and more vulnerable to pullback or digestion.
The model does not deploy this setup because extension risk is 86%, pullback risk is 60%, entry geometry is unfavorable at the current location, and recent price behavior has shown failed reversal memory. Predictability is 52%, agreement is 93%, and reversal risk is 33%.
NOTE: This next-day up/down probability forecast module is still being tested for accuracy. Please do not rely on it for investment decisions. The model does not account for black swan events or company-specific fundamental news, and its estimates are based solely on technical conditions, capital flow, and market sentiment. View forecast history
This reading is based on the last 20 trading days of 15-minute price, volume, and VWAP data. Price is trading 4.9% below the recent estimated cost basis of 202.98, so the recent structure is still leaning under pressure. Price is in the lower half of the main cost band (191.62 to 201.95), so price support and pullback behavior matter more than immediate upside follow-through. The broader structure still looks stretched on the weak side, so recovery attempts may need more proof before improving the tone. The higher up selling area sits around 195.79 to 196.19, so rebounds may begin to slow as price pushes into that zone. About 84% of recent positioning remains under water, which usually makes rallies harder to sustain. The main cost band is fairly wide relative to recent ATR, so this structure may behave less cleanly than a tighter setup. From a trading point of view, the main question is whether rebounds remain healthy enough to reach and absorb the higher overhead supply zone.